Recall archive / FDA drug enforcement
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313 — FDA record D-0332-2026
Reported ongoing
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Dec 22, 2025. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313
- Reason
- CGMP Deviations: product found to contain lead.
- Classification
- Class I
- Recalling firm
- HANDELNINE GLOBAL LLC
- Quantity
- 4 bottles /30 capsules each
- Agency-reported status
- Ongoing
- Source record identifier
- D-0332-2026
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Lot: CAM040, Exp. 06/30/2029 Lot: CAL079-N, Exp. 09/30/2028 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
Product was distributed to one customer in NY.
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
Dates in the source
- Report date
- Feb 11, 2026
- Recall initiation date
- Dec 22, 2025
- Center classification date
- Feb 12, 2026
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.